The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer

Chemotherapy is used as neoadjuvant therapy for all subgroups of breast cancer, including ER-positive, and HER2-negative cases. However, studies have suggested that using aromatase inhibitors combined with CDK4/6-inhibitors might be an appropriate alternative in selected patients. Thus, the NEOLETRI...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Fjermeros, Kamilla, Ghannoum, Salim, Geisler, Stephanie, Bhargava, Sameer, Tahiri, Andliena, Klajic, Jovana, Lüders, Torben, Fongård, Marie, Nawaz, Meh Sameen, Bosnjak-Olsen, Tatjana, Buvarp, Unn-Cathrin Edvardsen, Rosenskiold, Aino Katri Johanna, Nguyen, Nam Thi, Sletbak, Tone Tyskø, Seyedzadeh, Manouchehr, Selsås, Knut, Porojnicu, Alina Carmen, Skjerven, Helle, Hovda, Tone, Sahlberg, Guro Kristine Kleivi, Torland, Anne Vold, Lyngra, Marianne, Hammarström, Clara Louise, Hönigsperger, Elma Bahonjic, Noone, John Christopher, Mathiassen, Silje, Hurtado, Antoni, Goel, Shom, Koff, Andrew, Tekpli, Xavier, Kristensen, Vessela N, Geisler, Jürgen
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast neoplasms Gastrointestinal microbiome Neoadjuvant therapy
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!